INTRADUCTAL PAPILLARY MUCINOUS TUMORS OF THE PANCREAS - CLINICAL AND THERAPEUTIC ISSUES IN 32 PATIENTS

Citation
C. Azar et al., INTRADUCTAL PAPILLARY MUCINOUS TUMORS OF THE PANCREAS - CLINICAL AND THERAPEUTIC ISSUES IN 32 PATIENTS, Gut, 39(3), 1996, pp. 457-464
Citations number
36
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
39
Issue
3
Year of publication
1996
Pages
457 - 464
Database
ISI
SICI code
0017-5749(1996)39:3<457:IPMTOT>2.0.ZU;2-T
Abstract
Background/Aim-The clinical presentation, pancreatographic findings, a nd outcome of patients with intraductal papillary mucinous tumours hav e not been reported in a large patient series in the English literatur e. This study reviewed 32 patients diagnosed between 1980 and 1994, wi th special attention to these features. Patients/Method-Data on 24 ope rated and eight non-operated patients were abstracted from inpatient, outpatient, and procedure records. Results-Acute pancreatitis was the most common presentation seen in 56% of patients. Relapses occurred du ring an average of 43 months before diagnosis. A patulous papilla was observed in 55% of the cases. Endoscopic pancreatography showed commun icating cysts, a diffusely dilated main pancreatic duct, and amorphous defects in 42, 71, and 97% respectively. An invasive carcinoma was fo und in nine of 24 (37.5%) of operated patients: six of the patients (6 6%) died or developed metastases within three years after surgery. No mortality was related to the tumour in absence of invasive carcinoma. Benign recurrence on the remaining pancreas was unusual and occurred l ate after surgery. Conclusions-Intraductal papillary mucinous tumours must be considered in the differential diagnosis of relapsing pancreat itis. Despite slow growing, these tumours have an obvious malignant po tential and a very poor prognosis when invasive carcinoma has develope d. Early recognition and resection are the cornerstones of treatment.